arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

SeaStar Medical Holding Corp

ICU
$3.27 ▲ +0.22 (+7.21%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
22 Visible periods
25 Metrics
Peer-ranked Benchmarks
Price Chart
25
Health
Poor
Bearish
auto_awesome

Analytical Summary

SeaStar Medical Holding Corp faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $12.8M
Dividend Yield
Revenue Growth 68.9%
Op. Margin
ROIC -49.3%
FCF / Share $-0.70
Trailing P/E
Price / Book 1.8x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

22-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$495.00K
↑ +68.9%
Net Income Profit after all expenses
$-3.52M
↑ +6.7%
FCF / Share Free cash flow per share
$-0.70
↓ -128.8%
Long-Term Debt Long-term obligations
$0.00
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
7
Cash Quality
70

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 22 quarters